Gregson v. Secretary of the Dept. of Health & Human Services

17 Cl. Ct. 19, 1989 U.S. Claims LEXIS 77, 1989 WL 50600
CourtUnited States Court of Claims
DecidedMay 16, 1989
DocketNo. 88-1V
StatusPublished
Cited by5 cases

This text of 17 Cl. Ct. 19 (Gregson v. Secretary of the Dept. of Health & Human Services) is published on Counsel Stack Legal Research, covering United States Court of Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Gregson v. Secretary of the Dept. of Health & Human Services, 17 Cl. Ct. 19, 1989 U.S. Claims LEXIS 77, 1989 WL 50600 (cc 1989).

Opinion

OPINION AND ORDER

SMITH, Chief Judge.

This case is before the court on respondent’s Motion to Suspend Proceedings for 90 days in this case and in all other cases filed in the court under the National Vaccine Injury Compensation Program (hereinafter the Vaccine Act or Act). 42 U.S.C. § 300aa-10 et seq. (1988). Respondent’s motion also informs the court of respondent’s intention to limit participation by counsel to “such action as is contemplated by 42 U.S.C. § 300aa-12(d)(l).”

The court conducted a hearing on this matter on May 5, 1989, during which respondent’s counsel appeared and argued in support of its motion. The court also invited all petitioners’ counsel to attend and participate in the hearing. Seven petitioners’ counsel, appearing on behalf of nearly 20 other petitioners’ counsel, together representing over 60 petitioners, argued against the granting of respondent’s motion.

After hearing argument on the motion and considering the extraordinary nature of respondent’s request, the court denied respondent’s motion for two weeks through May 19, 1989, to give the court time to consider and issue a final written ruling. After considering the respective arguments of the parties and for the reasons set forth below, the court denies respondent’s motion. In addition, as set forth on pages 15-16, infra, respondent’s counsel is ordered to clarify its role as counsel in these cases before the court.

Background

The Vaccine Act created a new system for providing compensation for injuries or deaths resulting from vaccines routinely administered to children. See § 300aa-10(a). Under the compensation system, petitioners are entitled to an award if it is proven that petitioner developed specified symptoms or reactions to a vaccine within specified periods of time and subsequently suffered a vaccine-related injury for at least six-months or petitioner’s child died from the administration of the vaccine. § 300aa-13(a)(l)(A). Upon petitioner’s adequate showing, compensation will be awarded subject only to respondent proving an alternative cause of the injury. § 300aa-13(a)(l)(B).

The Vaccine Act classifies cases as prospective and retroactive, depending on whether the vaccine was administered after or before October 1, 1988, the effective date of the Vaccine Act. All individuals injured by a vaccine administered after October 1, 1988, seeking more than $1,000 in damages are required to exhaust their available remedies under the Vaccine Act before pursuing other civil remedies. § 300aa-ll(a)(2)(A). On the other hand, the filing of a retroactive case is optional. Retroactive cases may consist of claims that were never pursued through litigation, civil actions that were denied or dismissed with prejudice, or cases presently pending in state or federal court where the petitioner elects to withdraw such action without prejudice and file under the Act. See § 300aa-ll(a).

Following the receipt of a petition under the Act, the court is required to designate a special master to carry out certain functions. § 300aa-12(c). The special master, serving as an adjunct to the court, may [21]*21require the submission of such information, the production of any document and the testimony of any person as may be reasonable and necessary to determine if compensation is warranted. § 300aa-12(c)(2). The special master may conduct such hearings as may be appropriate in gathering the necessary evidence. Id. In recommending a decision on the appropriateness of compensation, the special master may prepare and submit to the court proposed findings of fact and conclusions of law. Id.

After the filing of the special master’s recommended decision and upon objection of the parties, or upon the court’s own motion, the court is to review the special master’s decision. § 300aa-12(d)(l). The court may remand for further proceedings, adopt the proposed findings of fact and conclusions of law and render judgment thereon, or make a de novo determination of any matter and issue its judgment accordingly. In any event, the court is to render its judgment within 365 days after the filing of the petition. § 300aa-12(d)(3).

Upon entry of judgment by the Claims Court, petitioner must then elect to accept or reject the court’s judgment. § 300aa-21(a). Acceptance of the court’s judgment bars any future action against the vaccine manufacturer for the vaccine-related injury or death. Id. If the petitioner rejects the court’s judgment, the petitioner may pursue a common law tort action in state or federal court. Id.

Issues Presented

Respondent’s argument on behalf of its motion was essentially that the combination of the Vaccine Act’s 365-day decision requirement, the lack of sufficient resources (mainly the number of attorneys and doctors at the Department of Justice and the Department of Health and Human Services) and the court’s procedures for handling the vaccine cases have created a system of competing pressures which threaten to cause the program to grind to a halt. Respondent stated that now is an appropriate time to stop and examine how the system is working since all parties concerned have several months of experience with the program and no prospective cases have yet been filed under the Act.

While respondent stated that a confluence of three specific problems has given rise to a larger and more general problem, respondent’s argument focused mainly on the manner in which the court is processing the vaccine cases. Respondent repeatedly referred to “complex traditional litigation” to describe the court’s method of handling the cases. For support of this characterization, respondent referenced detailed discovery orders with short court imposed time-frames for dealing with the orders, a “regimen of daily status conferences”, and new assignments flowing from the status conferences. Transcript of May 5, 1989, Hearing on Respondent’s Motion to Suspend Proceedings, pp. 14-15 (hereinafter Tr. at -)1. These preliminary events then lead to the decisive hearing stage where, respondent stated, detailed prehearing orders are issued which:

set a prehearing conference seven [to] ten days before the hearing requiring counsel to provide memoranda of law and fact with legal authority, a witness list very explicit with summaries of the witnesses, an exhibit list with separate statements of what each exhibit is going to contain; a separate and joint memorandum of stipulations divided into two parts, the first part what we could stipulate to, the second part what we cannot, but in a very detailed way [and a] joint statement setting forth the issues of fact and issues of law in sufficient detail to enable the Court to resolve the case in its entirety by addressing each of the issues listed.

Tr. at 15. Respondent averred that the Vaccine Act did not contemplate the use of such detailed procedures but instead envisioned a more streamlined approach to the handling of the vaccine cases.

Petitioners’ view of the current system was one in sharp contrast to that of respondent. The seven petitioners’ counsel ad[22]*22vanced separate but similar arguments against respondent’s suspension motion2.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
17 Cl. Ct. 19, 1989 U.S. Claims LEXIS 77, 1989 WL 50600, Counsel Stack Legal Research, https://law.counselstack.com/opinion/gregson-v-secretary-of-the-dept-of-health-human-services-cc-1989.